Device Trial Radar · NCT04392349
Clinical Study - ES 900 - 2020-2
Last checked: Nov 19, 2026Latest source record: Mar 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
29
Actual
Start
Jul 1, 2020
Primary completion
Aug 20, 2020
Study completion Dec 10, 2020
Sponsor
- Lead sponsor
- Haag-Streit AGNot on our public-company list
- Sponsor type
- Industry
- First posted
- May 18, 2020
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The EYESTAR 900 with software version i9.5.1.0 includes new analysis functionality. Since its clinical performance cannot be assessed based solely on clinical literature as found in the Clinical Evaluation Report, further data from a clinical trial is required. The objective of this trial is to assess the clinical performance of the new features of the EYESTAR 900 with software version i9.5.1.0. This study is a necessary part of the clinical evaluation process of the investigational device. The results of this study are used for the clinical evaluation, and for reporting of in-vivo repeatabilities in the instructions for use of the investigational device, as required by topography standards.
Conditions
- Cataract
- Keratoconus
Interventions
Haag-Streit EYESTAR 900Device
The EYESTAR 900 is a new device developed by HAAG-STREIT AG which utilises Optical Coherence Tomography (OCT) for quantitative measurements of the geometry of the eye. As a successor to the LENSTAR 900, it represents the most recent in a series of successful biometry devices.
Tomey CASIA 2Device
The CASIA2 is a testing application for Cataract / Glaucoma / Cornea Surgery already established on the market. It is a representative device for measurement of anterior and posterior corneal curvature (anterior and posterior corneal topography) by optical coherence tomography, and for measurement of crystalline lens tilt by optical coherence tomography.
Oculus PENTACAM HRDevice
The Pentacam HR is a high-resolution rotating Scheimpflug camera system for anterior segment analysis already established on the market. It is used as representative device for advanced anterior segment analysis such as anterior and posterior corneal topography and corneal pachymetry.
Zeiss ATLAS 9000Device
ATLAS is a corneal topography system used as representative device for measurement of anterior corneal curvature (anterior corneal topography).
Primary outcomes
What the sponsor says the trial is designed to measure.
- In-vivo RepeatabilityTime frame: 3 months
- Limits of AgreementTime frame: 3 months
- Confidence Interval of DifferencesTime frame: 3 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University Hospital Basel
Basel, Switzerland
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.